Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor Versus G-CSF in WHIM Syndrome
NCT02231879Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2014
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plerixafor in WHIM syndrome (WHIM), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2014; status: completed.
02
Drugs
plerixafor
03
Conditions
WHIM syndrome (WHIM)
Beyond the preview
Go deeper on NCT02231879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02231879.